Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

KeyCorp a un objectif de cours consensus de $19.54, basé sur les évaluations des 25 analystes. Le plus élevé est de $24 attribué par Morgan Stanley le septembre 29, 2025, et le plus bas est de $16 attribué par Argus Research le avril 19, 2024. Les 3 dernières évaluations d'analystes ont été publiées par DA Davidson, Truist Securities et UBS le octobre 17, 2025, octobre 17, 2025 et octobre 7, 2025. Avec un objectif de cours moyen de $21 entre DA Davidson, Truist Securities et UBS, il y a une variation implicite de 18.39% upside pour KeyCorp à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/17/2025 | 18.39% | DA Davidson | $22 → $21 | Maintains | Buy | |||
10/17/2025 | 7.11% | Truist Securities | $20 → $19 | Maintains | Hold | |||
10/07/2025 | 29.66% | UBS | $22 → $23 | Maintains | Buy | |||
10/06/2025 | 12.75% | RBC Capital | $20 → $20 | Reiterates | Outperform → Outperform | |||
10/03/2025 | 24.03% | Wells Fargo | $20 → $22 | Maintains | Overweight | |||
09/30/2025 | 24.03% | Evercore ISI Group | $21 → $22 | Maintains | Outperform | |||
09/29/2025 | 35.3% | Morgan Stanley | $20 → $24 | Maintains | Equal-Weight | |||
07/28/2025 | 7.11% | Truist Securities | $17 → $19 | Maintains | Hold | |||
07/24/2025 | 12.75% | Citigroup | $19 → $20 | Downgrade | Buy → Neutral | |||
07/23/2025 | 18.39% | DA Davidson | $19 → $21 | Maintains | Buy | |||
07/08/2025 | 12.75% | Wells Fargo | $18 → $20 | Maintains | Overweight | |||
07/08/2025 | 24.03% | UBS | $16 → $22 | Upgrade | Neutral → Buy | |||
06/16/2025 | 12.75% | B of A Securities | $18 → $20 | Maintains | Buy | |||
05/21/2025 | 1.48% | Jefferies | → $18 | Initiates | → Hold | |||
04/22/2025 | -9.8% | Truist Securities | $18 → $16 | Maintains | Hold | |||
04/21/2025 | 1.48% | Keefe, Bruyette & Woods | $20 → $18 | Maintains | Outperform | |||
04/21/2025 | 12.75% | Barclays | $21 → $20 | Maintains | Equal-Weight | |||
04/07/2025 | 1.48% | Baird | $18 → $18 | Upgrade | Neutral → Outperform | |||
04/03/2025 | -6.98% | JP Morgan | $18.5 → $16.5 | Maintains | Neutral | |||
03/28/2025 | 12.75% | Wells Fargo | $22 → $20 | Maintains | Overweight | |||
03/24/2025 | 7.11% | Citigroup | $20 → $19 | Maintains | Buy | |||
03/21/2025 | 1.48% | Truist Securities | $19 → $18 | Maintains | Hold | |||
03/13/2025 | 12.75% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight | |||
03/10/2025 | 12.75% | Citigroup | → $20 | Upgrade | Neutral → Buy | |||
02/03/2025 | 4.3% | JP Morgan | → $18.5 | Assumes | → Neutral | |||
01/22/2025 | 1.48% | RBC Capital | $18 → $18 | Reiterates | Outperform → Outperform | |||
01/22/2025 | 12.75% | Stephens & Co. | $20 → $20 | Reiterates | Overweight → Overweight | |||
01/22/2025 | 18.39% | DA Davidson | $22 → $21 | Maintains | Buy | |||
01/22/2025 | 18.39% | Keefe, Bruyette & Woods | $22 → $21 | Maintains | Outperform | |||
01/22/2025 | 24.03% | Morgan Stanley | $23 → $22 | Maintains | Equal-Weight | |||
01/07/2025 | 7.11% | Truist Securities | → $19 | Initiates | → Hold | |||
01/06/2025 | 18.39% | Barclays | $19 → $21 | Maintains | Equal-Weight | |||
12/04/2024 | 24.03% | Keefe, Bruyette & Woods | $19 → $22 | Maintains | Outperform | |||
12/03/2024 | 24.03% | Piper Sandler | $19 → $22 | Maintains | Overweight | |||
11/26/2024 | 29.66% | Goldman Sachs | $20 → $23 | Maintains | Buy | |||
11/15/2024 | 24.03% | Wells Fargo | $20 → $22 | Maintains | Overweight | |||
11/07/2024 | 7.11% | Citigroup | → $19 | Downgrade | Buy → Neutral | |||
10/23/2024 | 1.48% | UBS | $17 → $18 | Maintains | Neutral | |||
10/21/2024 | 12.75% | DA Davidson | $19 → $20 | Maintains | Buy | |||
10/18/2024 | 7.11% | Barclays | $16 → $19 | Maintains | Equal-Weight | |||
10/18/2024 | 1.48% | RBC Capital | $17 → $18 | Maintains | Outperform | |||
10/14/2024 | -4.16% | Baird | $18 → $17 | Downgrade | Outperform → Neutral | |||
10/02/2024 | 12.75% | Evercore ISI Group | $18.5 → $20 | Maintains | Outperform | |||
09/24/2024 | 1.48% | Wedbush | $17 → $18 | Maintains | Neutral | |||
09/10/2024 | 1.48% | Keefe, Bruyette & Woods | $18 → $18 | Maintains | Outperform | |||
08/19/2024 | 7.11% | Jefferies | $18 → $19 | Maintains | Buy | |||
08/14/2024 | 12.75% | Morgan Stanley | $18 → $20 | Maintains | Equal-Weight | |||
08/13/2024 | -4.16% | RBC Capital | $17 → $17 | Reiterates | Outperform → Outperform | |||
08/13/2024 | 7.11% | Citigroup | $18 → $19 | Maintains | Buy | |||
08/13/2024 | -4.16% | Wedbush | $16 → $17 | Maintains | Neutral | |||
08/05/2024 | 1.48% | Morgan Stanley | $16 → $18 | Maintains | Equal-Weight | |||
07/19/2024 | -4.16% | RBC Capital | $16 → $17 | Maintains | Outperform | |||
07/19/2024 | 1.48% | DA Davidson | $16 → $18 | Maintains | Buy | |||
07/19/2024 | -9.8% | Wedbush | $15 → $16 | Maintains | Neutral | |||
07/08/2024 | -15.44% | UBS | $16 → $15 | Downgrade | Buy → Neutral | |||
06/27/2024 | -6.98% | JP Morgan | $17.5 → $16.5 | Maintains | Neutral | |||
06/25/2024 | -6.98% | Evercore ISI Group | — | $17.5 → $16.5 | Maintains | Outperform | ||
06/25/2024 | 131.14% | RBC Capital | $41 → $41 | Reiterates | Outperform → Outperform | |||
06/14/2024 | -1.34% | JP Morgan | $18 → $17.5 | Maintains | Neutral | |||
04/19/2024 | -9.8% | RBC Capital | $15 → $16 | Maintains | Outperform | |||
04/19/2024 | -9.8% | Argus Research | $15 → $16 | Maintains | Buy | |||
04/08/2024 | 1.48% | Jefferies | $17 → $18 | Maintains | Buy | |||
04/05/2024 | 1.48% | Keefe, Bruyette & Woods | $16 → $18 | Maintains | Outperform | |||
04/04/2024 | 1.48% | JP Morgan | $16 → $18 | Maintains | Neutral | |||
03/28/2024 | 1.48% | Wells Fargo | $16 → $18 | Maintains | Overweight | |||
03/28/2024 | 1.48% | Evercore ISI Group | — | $17 → $18 | Maintains | Outperform | ||
02/07/2024 | -9.8% | Morgan Stanley | $12 → $16 | Maintains | Equal-Weight | |||
01/26/2024 | -4.16% | Piper Sandler | $16 → $17 | Maintains | Overweight | |||
01/19/2024 | -9.8% | DA Davidson | $17 → $16 | Maintains | Buy | |||
01/19/2024 | — | Keefe, Bruyette & Woods | — | Maintains | Outperform | |||
01/19/2024 | -15.44% | RBC Capital | $13 → $15 | Maintains | Outperform | |||
01/19/2024 | -21.07% | Wedbush | $16 → $14 | Maintains | Neutral | |||
01/19/2024 | -9.8% | Barclays | $17 → $16 | Maintains | Equal-Weight | |||
01/09/2024 | -4.16% | Jefferies | $10 → $17 | Upgrade | Hold → Buy | |||
01/08/2024 | — | Raymond James | — | Initiates | → Market Perform | |||
01/03/2024 | -4.16% | Keefe, Bruyette & Woods | $15 → $17 | Maintains | Outperform | |||
01/02/2024 | -4.16% | Barclays | $13 → $17 | Maintains | Equal-Weight | |||
12/20/2023 | — | Stephens & Co. | — | Upgrade | Equal-Weight → Overweight | |||
12/18/2023 | -15.44% | Goldman Sachs | $13.5 → $15 | Maintains | Buy | |||
12/14/2023 | -9.8% | Wells Fargo | $12 → $16 | Maintains | Overweight | |||
12/05/2023 | -26.71% | Stephens & Co. | $13 → $13 | Reiterates | Equal-Weight → Equal-Weight | |||
12/05/2023 | -26.71% | RBC Capital | $14 → $13 | Maintains | Outperform | |||
12/04/2023 | -32.35% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight | |||
11/06/2023 | -15.44% | Keefe, Bruyette & Woods | → $15 | Upgrade | Market Perform → Outperform | |||
10/05/2023 | -32.35% | JP Morgan | $13 → $12 | Maintains | Neutral | |||
10/04/2023 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
09/27/2023 | -37.99% | Morgan Stanley | $10 → $11 | Maintains | Equal-Weight | |||
09/15/2023 | -23.89% | Piper Sandler | $12 → $13.5 | Upgrade | Neutral → Overweight | |||
08/02/2023 | — | JP Morgan | — | Upgrade | Underweight → Neutral | |||
07/24/2023 | -21.07% | Argus Research | $17 → $14 | Maintains | Buy | |||
07/24/2023 | -15.44% | Citigroup | $14 → $15 | Maintains | Buy | |||
07/24/2023 | -26.71% | Goldman Sachs | $11.5 → $13 | Maintains | Buy | |||
07/21/2023 | -43.62% | Morgan Stanley | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | |||
07/21/2023 | -26.71% | Wedbush | $10 → $13 | Maintains | Neutral | |||
07/21/2023 | -26.71% | Goldman Sachs | $11.5 → $13 | Maintains | Buy | |||
07/12/2023 | -21.07% | Citigroup | $15 → $14 | Maintains | Buy | |||
07/07/2023 | -43.62% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight | |||
06/29/2023 | -40.81% | JP Morgan | $11 → $10.5 | Maintains | Underweight | |||
06/13/2023 | -21.07% | RBC Capital | $16 → $14 | Maintains | Outperform | |||
06/13/2023 | -37.99% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
Le dernier objectif de prix pour KeyCorp (NYSE:KEY) a été rapporté par DA Davidson le octobre 17, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $21.00 s'attendant à ce que KEY se rise dans les 12 prochains mois (un possible changement de 18.39% upside). 37 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour KeyCorp (NYSE:KEY) a été fournie par DA Davidson, et KeyCorp maintenu leur note buy.
La dernière amélioration pour KeyCorp a eu lieu le juillet 8, 2025 lorsque UBS a augmenté leur objectif de prix à $22. UBS avait précédemment a neutral pour KeyCorp.
La dernière réduction pour KeyCorp a eu lieu le juillet 24, 2025 lorsque Citigroup a changé leur objectif de prix de $19 à $20 pour KeyCorp.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de KeyCorp, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour KeyCorp a été déposée le octobre 17, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 17, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de KeyCorp (KEY) était un maintenu avec un objectif de prix de $22.00 à $21.00. Le prix actuel de KeyCorp (KEY) est de $17.74, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.